25/05/2022

European Week Against Cancer 2022 – Interview with Santiago Aguirre, Market Lead Europe Oncology, Sanofi

04/04/2022

EuropaBio NAC Summit 2022: key recommendations on how National associations can deliver Europe’s innovation, investment and excellence in biotechnology

28/02/2022

EuropaBio Statement on Rare Disease Day

13/12/2021

Interview with Ingmar Hoerr, CureVac Founder and holder of the first patents associated with mRNA

EuropaBio sat down with New Member Olon, to find out about their Plans to Expand their Biotechnology Platform.
22/11/2021

The review of the general pharmaceutical legislation: an opportunity that should not be missed?

26/10/2021

Healthy Planet, Healthy People: a Pathway for Green Transition in the Biopharmaceutical Ecosystem

19/10/2021

EuropaBio Patient Bio-Forum: challenges and future potential of European Reference Networks

30/09/2021

Artificial intelligence: investing in new technologies in healthcare

What if machine learning and artificial intelligence could learn to detect one of the most common forms of blood cancer, through evaluating data based on the gene activity of blood cells?
02/08/2021

EuropaBio response to the European Commission Public Consultation on the Regulations for Orphan Medicinal Products and Paediatrics

EuropaBio has responded to the European Commission’s public consultation on the Orphan Medicinal Products (OMPs) and Paediatrics Regulations.
26/07/2021

EuropaBio response to the European Commission Public Consultation on the Regulation for Orphan Medicinal Products and Paediatrics: the value brought by the technology to patients and society should be well recognised

20/07/2021

EuropaBio’s response to the EC consultation on patients’ rights in cross-border healthcare

16/06/2021

EPSCO Council conclusions: EuropaBio calls for more pragmatic approach addressing access, availability and affordability of medicines

07/06/2021

Pragmatic IP solutions and strong collaborations will ensure faster global access to vaccines

25/05/2021

Alliance for Regenerative Medicine, European Federation of Pharmaceutical Industries and Associations, and European Association for Bioindustries Call for Advanced Therapies to be Exempt from EU GMO Legislation

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
20/05/2021

EuropaBio Patient BioForum: Advancing Patient Access to Innovative Treatments

29/04/2021

EuropaBio on NGT study: A positive step towards delivering innovation

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
16/04/2021

Online Roundtable Report: An EU Vision For Life Science and Biotechnology for a Healthy and Sustainable EU

Webinar Report.
16/04/2021

EuropaBio Response to the Public Consultation on Blood, tissues and cells for medical treatments & therapies

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
31/03/2021

EuropaBio response to the EGE report ‘Ethics of Genome Editing’

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
25/03/2021

EuropaBio Statement – Vaccine production scale up: International collaboration remains the key

EuropaBio Statement – Vaccine production scale up: International collaboration remains the key.
Become a member